Status:
RECRUITING
PREG - Offspring: Investigation of Children From Mothers With and Without Gestational Diabetes
Lead Sponsor:
University Hospital Tuebingen
Conditions:
Offspring Exposed to GDM and Control
Eligibility:
All Genders
6-17 years
Brief Summary
Gestational diabetes is the most common complication during pregrancy. With a screening between week 24 and 28 of gestation women with gestational diabetes can be identified and treated. Treatment com...
Eligibility Criteria
Inclusion
- signed informed consent provided by child and parent
- documented oral glucose tolerance test of the mother during pregnancy
- adequate management of gestational diabetes until birth
Exclusion
- severe malformation that makes an examination impossible
- existent of coagulation disorder with increased risk of bleeding after blood sampling
Key Trial Info
Start Date :
January 15 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 15 2036
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04722900
Start Date
January 15 2021
End Date
September 15 2036
Last Update
September 2 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Tübingen
Tübingen, Germany, 72076